Results 31 to 40 of about 3,176,177 (307)

Rectal metastasis of gastric cancer: a case report

Journal of International Medical Research, 2023
The most common metastatic sites of gastric cancer include the liver, peritoneum, lung, and bone. However, there is a lack of relevant clinical reports regarding rectal metastasis.
Lu Tang, Huifen Li, Jing Lv, Cantu Fang, Huatang Zhang, Jincheng Meng   +5 more
doaj   +1 more source

Laparoscopy for Rectal Cancer [PDF]

Clinics in Colon and Rectal Surgery, 2017
It is evident that the use of laparoscopy in the management of rectal cancer has gained popularity in the last few years. It is still, however, not widely accepted as the standard of care. Multiple randomized trials have shown that short-term outcomes and perioperative morbidity and mortality of laparoscopic proctectomy are equivalent to open surgery ...
Chady, Atallah, Jonathan E, Efron
openaire   +2 more sources

Pathological and molecular features of sporadic rectal cancer in young adults [PDF]

, 2022
openBackground Incidence of early-onset sporadic rectal cancer is rising globally but the reasons are still unclear. Cancer among young adults has different features from late-onset cancer, such as an advanced stage at diagnosis, mucinous differentiation,
TAMPONI, GIULIA
core  

Differences in survival between colon and rectal cancer from SEER data. [PDF]

PLoS ONE, 2013
BACKGROUND: Little is known about colorectal cancer or colon and rectal cancer. Are they the same disease or different diseases? OBJECTIVES: The aim of this epidemiology study was to compare the features of colon and rectal cancer by using recent ...
Yen-Chien Lee, Yen-Lin Lee, Jen-Pin Chuang, Jenq-Chang Lee   +3 more
doaj   +1 more source

MicroRNA in rectal cancer

World Journal of Gastrointestinal Oncology, 2016
In rectal cancer, one of the most common cancers worldwide, the proper staging of the disease determines the subsequent therapy. For those with locally advanced rectal cancer, a neoadjuvant chemoradiotherapy (CRT) is recommended before any surgery.
Azizian, Azadeh, Gruber, Jens, Ghadimi, B Michael, Gaedcke, Jochen   +3 more
openaire   +3 more sources

Relationship between quantitative analysis parameters of DCE-MRI and microangiogenesis in rectal cancer [PDF]

Zhongguo aizheng zazhi
Background and purpose: Tumor microangiogenesis is an important basis for tumor growth and metastasis, and its characteristics include angiogenesis, increased vascular permeability and abnormal capillary structure.
SONG Dan, CHAI Yaxin, GE Yanping
doaj   +3 more sources

Identification of genes inducing resistance to ionizing radiation in human rectal cancer cell lines: re-sensitization of radio-resistant rectal cancer cells through down regulating NDRG1

BMC Cancer, 2018
Background Resistance to preoperative radiotherapy is a major clinical problem in the treatment for locally advanced rectal cancer. The role of NDRG1 in resistance to ionizing radiation in rectal cancer has not been fully elucidated.
Soon-Chan Kim, Young-Kyoung Shin, Ye-Ah Kim, Sang-Geun Jang, Ja-Lok Ku   +4 more
doaj   +1 more source

Enteropathogenic E. coli shows delayed attachment and host response in human jejunum organoid‐derived monolayers compared to HeLa cells

FEBS Letters, EarlyView.
Enteropathogenic E. coli (EPEC) infects the human intestinal epithelium, resulting in severe illness and diarrhoea. In this study, we compared the infection of cancer‐derived cell lines with human organoid‐derived models of the small intestine. We observed a delayed in attachment, inflammation and cell death on primary cells, indicating that host ...
Mastura Neyazi, Pilar Samperio Ventayol, Natalie Burkard, Nicolas Schlegel, Carmen Aguilar, Sina Bartfeld   +5 more
wiley   +1 more source

Diagnostic accuracy systematic review of rectal bleeding in combination with other symptoms, signs and tests in relation to colorectal cancer [PDF]

, 2010
Background: Rectal bleeding is a recognised early symptom of colorectal cancer. This study aimed to assess the diagnostic accuracy of symptoms, signs and diagnostic tests in patients with rectal bleeding in relation to risk of colorectal cancer in ...
Bekkink, M. Olde, C Teljeur, Teljeur, C., Van de Laar, F. A., C McCowan, Fahey, T., Van de Laar, F.A., M Olde Bekkink, Olde Bekkink, M., Falk, G.A., G A Falk, Mccowan, C., F A Van de Laar, Laar, F.A. Van de, T Fahey, Falk, G. A.   +15 more
core   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

Molecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington, Divya L. Dayanidhi, Mohammad Zokaasadi, John B. Mantyh, Pelumi D. Olawuni, Gabrielle Rupprecht, Jeremy M. Force, Shannon McCall, Ashwani K. Bahl, David S. Hsu, Jason A. Somarelli   +10 more
wiley   +1 more source